To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Energy Employees Occupational Illness Compensation Program for fiscal year 2024.
Impact
The implementation of HB 1970 would directly affect the operational capabilities of the CDC in addressing health concerns for energy employees, who may seek compensation for work-related illnesses. By capping the funding, the bill may hinder the CDC's ability to adequately support these individuals, raising concerns about the potential decrease in healthcare services and support for affected workers. Proponents of the bill may argue for fiscal responsibility; however, critics may highlight the risks it poses to vulnerable populations who rely on these health programs.
Summary
House Bill 1970 seeks to establish a funding limitation for the Department of Health and Human Services, particularly focusing on the Centers for Disease Control and Prevention's Energy Employees Occupational Illness Compensation Program for the fiscal year 2024. The proposed cap sets the fund availability at a maximum of $55,358,000, which could influence the allocation of resources to those affected by occupational illnesses related to energy sectors. This limitation is part of broader discussions on government spending and resource allocation at the federal level.
Contention
Debates surrounding HB 1970 are likely to encompass views on fiscal conservatism versus social responsibility regarding health care funding. Additionally, lawmakers may engage in discussions about the implications of limiting funds for public health programs, particularly in the context of workforce health and safety measures. The contention arises from balancing budgetary constraints while ensuring adequate support for individuals suffering from occupational illnesses, with advocates arguing that limiting funds undermines their health and well-being.
Domestic Security Using Production Partnerships and Lessons from Yesterday Act of 2023 or the Domestic SUPPLY Act of 2023 This bill establishes a program and sets out other requirements to promote domestic manufacturing of personal protective equipment (PPE) for infectious diseases and other public health emergencies. The Department of Health and Human Services (HHS) must establish a program to enter into purchasing agreements for PPE produced domestically by manufacturers that are majority-owned and -operated by U.S. citizens. HHS must coordinate with the Department of Defense and the Department of Homeland Security on this program. In addition, the federal government must only procure, subject to limited exceptions, PPE that is produced domestically to prevent the transmission of an infectious disease. If using federal funds, states or localities must also procure PPE domestically. Further, the bill requires HHS to consult with the Occupational Safety and Health Administration on a report about changes to federal requirements for PPE during the COVID-19 pandemic and the impact of those changes on health care workers who cared for patients in 2020 and 2021.
Triple-Negative Breast Cancer Research and Education Act of 2023 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
No Pro-Abortion Task Force Act This bill prohibits federal funding of the Reproductive Healthcare Access Task Force. The Department of Health and Human Services launched the task force on January 21, 2022, to identify and coordinate departmental activities related to accessing sexual and reproductive health care.
Freedom for Farmers Act of 2023 This bill abolishes the Agency for Toxic Substances and Disease Registry. This agency, which is part of the Department of Health and Human Services (HHS), investigates and responds to environmental exposures to hazardous substances in communities. HHS must transfer authority regarding certain national disease and toxic exposure registries to another appropriate HHS entity.